⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 1, 2004Clinical Cancer ResearchOpen Access

Reducing the Immune Response to Immunotoxin

View Full Paper

Ask AI

Bookmark

Share

Authors

AFArthur E. FrankelTexas A&M Health Science Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Arthur E. Frankel (2004) studied this question.

synapsesocial.com/papers/6a8d0b7152f536cb0a1cd203 https://doi.org/10.1158/1078-0432.ccr-1216-3

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

1Human pancreatic RNase1-human epidermal growth factor fusion: an entirely human 'immunotoxin analog' with cytotoxic properties against squamous cell carcinomas1998 · 47 citations
2Phase I/II Study of Murine Monoclonal Antibody-Ricin A Chain (XOMAZYME-Mel) Immunoconjugate plus Cyclosporine A in Patients with Metastatic Melanoma1993 · 51 citations
3An anti‐CD5 immunotoxin for chronic lymphocytic leukemia: Enhancement of cytotoxicity with human serum albumin‐monensin1989 · 64 citations